Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kaposi Sarcoma Chemotherapy and Research (KS-CARE): Clinical and Molecular Determinants of HIV-associated Kaposi Sarcoma Progression Under Local Standard-of-care Therapy in Malawi and South Africa

NCT06480773 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT06480773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06480773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kaposi Sarcoma Chemotherapy and Research (KS-CARE): Clinical and Molecular Determinants of HIV-associated Kaposi Sarcoma Progression Under Local Standard-of-care Therapy in Malawi and South Africa
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
April 25, 2023
Completion date
December 31, 2026
Enrollment
127 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, kaposi sarcoma